Effects of cyclazocine and scopolamine on swim-to-platform performance in rats.
Brain Res
; 922(2): 229-33, 2001 Dec 20.
Article
en En
| MEDLINE
| ID: mdl-11743954
DL-Cyclazocine (0.5-2.0 mg/kg, i.p.) produced no impairment in rats' acquisition and retention of the behavior of swimming to a large visible platform in a water tank. However, cyclazocine produced a significant enhancement or potentiation of the impairment in swim-to-platform behavior produced by scopolamine. Since cyclazocine has previously been shown to abolish serotonin-dependent electrocortical activation (enabling it, in combination with central muscarinic blockade, to block all cortical activation), the results lend further support to the hypothesis that blockade of electrocortical activation produces dementia rather than sleep or coma as was previously believed.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Escopolamina
/
Corteza Cerebral
/
Antagonistas Muscarínicos
/
Ciclazocina
/
Electroencefalografía
/
Aprendizaje
/
Antagonistas de Narcóticos
Límite:
Animals
Idioma:
En
Revista:
Brain Res
Año:
2001
Tipo del documento:
Article
País de afiliación:
Canadá
Pais de publicación:
Países Bajos